Information about Iopidine Unit Dose Drops (Apraclonidine)
Iopidine unit dose drops contain apraclonidine, an alpha-2 adrenergic agonist designed for ophthalmic use. These drops are provided in single-use containers to ensure sterility and ease of application. They are primarily used to manage intraocular pressure (IOP) in patients with glaucoma or ocular hypertension.
Product Highlights
- The reduction of intraocular pressure in patients with glaucoma or ocular hypertension, particularly after surgical interventions.
Key Ingredient
Key Benefits
- Rapidly lowers intraocular pressure, providing relief for glaucoma patients.
- Single-use vials minimize the risk of contamination and ensure proper dosing.
- Generally well-tolerated with fewer systemic side effects compared to some other IOP-lowering agents.
Direction of Use
- Administer one drop in the affected eye(s) as directed by a healthcare provider, typically up to three times daily.
- Ensure proper hygiene by washing hands before and after application.
- Use immediately after opening a unit dose vial and discard any unused portion.
Safety Concerns
- Common side effects may include eye irritation, dry mouth, and drowsiness.
- Potential for allergic reactions or sensitivity, particularly in patients with a history of hypersensitivity to alpha-2 agonists.
- Caution is recommended for patients with cardiovascular conditions, as systemic absorption can occur.
Avoid Iopidine Unit Dose Drops (Apraclonidine) If
- You have a known allergy to apraclonidine or any component of the formulation.
- You are currently taking monoamine oxidase inhibitors (MAOIs) or have recently stopped.
- You have a history of severe cardiovascular disease or specific arrhythmias.
- You are pregnant or breastfeeding without prior consultation with a healthcare professional.
